2025

• Frøen, Hege; Brodtkorb, Marianne; Holte, Harald; Kolstad, Arne; Myhre, Anders Eivind; Remberger, Mats. (2025) Allogen stamcelletransplantasjon for pasienter med lymfom 2011–21. Tidsskrift for Den norske legeforening (Tidsskriftet)
  Academic article

2024

• Dreyling, Martin; Fowler, Nathan Hale; Dickinson, Michael; Martinez-Lopez, Joaquin; Kolstad, Arne; Butler, Jason. (2024) Durable response after tisagenlecleucel in adults with relapsed/refractory follicular lymphoma: ELARA trial update. Blood
  Academic article
• Rodrigues, Joana M.; Hollander, Peter; Schmidt, Lina; Gkika, Eirinaios; Razmara, Masoud; Kumar, Darshan. (2024) MYC protein is a high-risk factor in mantle cell lymphoma and identifies cases beyond morphology, proliferation and TP53/p53 - a Nordic Lymphoma Group study. Haematologica
  Academic article
• Malinverni, Chiara; Bernardelli, Andrea; Glimelius, Ingrid; Mirandola, Massimo; Smedby, Karin E.; Tisi, Maria Chiara. (2024) Outcomes of younger patients with mantle cell lymphoma experiencing late relapse (>24 months): the LATE-POD study. Blood
  Academic article
• Jerkeman, Mats; Kolstad, Arne; Hutchings, Martin; Pasanen, Annika; Meriranta, Leo; Niemann, Carsten Utoft. (2024) MRD-driven treatment with venetoclax-R2 in mantle cell lymphoma: the Nordic Lymphoma Group MCL7 VALERIA trial. Blood Advances
  Academic article
• Ask, Eivind Heggernes; Tschan-Plessl, Astrid; Hoel, Hanna Julie; Kolstad, Arne; Holte, Harald; Malmberg, Karl-Johan. (2024) MetaGate: Interactive analysis of high-dimensional cytometry data with metadata integration. Patterns
  Academic article

2023

• Földvári, Zsofia; Knetter, Cathrine; Yang, Weiwen; Gjerdingen, Thea Johanne; Bollineni, Ravi Chand; Tran, Trung. (2023) A systematic safety pipeline for selection of T-cell receptors to enter clinical use. npj Vaccines
  Academic article
• Spasevska, Ivana; Sharma, Ankush; Steen, Chloe Beate; Josefsson, Sarah Elisabet; Blaker, Yngvild Nuvin; Kolstad, Arne. (2023) Diversity of intratumoral regulatory T cells in B-cell non-Hodgkin lymphoma. Blood Advances
  Academic article
• Nikkarinen, Anna; Lokhande, Lavanya; Amini, Rose-Marie; Jerkeman, Mats; Porwit, Anna; Molin, Daniel. (2023) Soluble CD163 predicts outcome in both chemoimmunotherapy and targeted therapy–treated mantle cell lymphoma. Blood Advances
  Academic article
• Salim, Ruth; Husby, Simon; Winther Eskelund, Christian; Scott, David W.; Holte, Harald; Kolstad, Arne. (2023) Exploring new prognostic biomarkers in Mantle Cell Lymphoma: a comparison of the circSCORE and the MCL35 score. Leukemia and Lymphoma
  Academic article
• Cicone, Francesco; Santo, Giulia; Bodet-Milin, Caroline; Cascini, Giuseppe Lucio; Kraeber-Bodéré, Françoise; Stokke, Caroline. (2023) Radioimmunotherapy of Non-Hodgkin B-cell Lymphoma: An update. Seminars in nuclear medicine
  Academic literature review

2022

• Sandström Gerdtsson, Anna; de Matos Rodrigues, Joana; Eskelund, Christian Winther; Husby, Simon; Grønbæk, Kirsten; Räty, Riikka. (2022) Overexpression of the key metabolic protein CPT1A defines mantle cell lymphoma patients with poor response to standard high-dose chemotherapy independent of MIPI and complement established high-risk factors. Haematologia
  Academic article
• Husby, Simon; Bæch-Laursen, Cecilie; Eskelund, Christian W.; Favero, Francesco; Jespersen, Jakob Schmidt; Hutchings, Martin. (2022) Clonal hematopoiesis is associated with hematological toxicity during lenalidomide-based therapy for MCL. Leukemia
  Letter to the editor
• Løndalen, Ayca; Blakkisrud, Johan; Rootwelt-Revheim, Mona Elisabeth; Dahle, Jostein; Kolstad, Arne; Stokke, Caroline. (2022) FDG PET/CT and Dosimetric Studies of 177Lu-Lilotomab Satetraxetan in a First-in-Human Trial for Relapsed Indolent non-Hodgkin Lymphoma—Are We Hitting the Target?. Molecular Imaging and Biology
  Academic article
• Malenge, Marion Masitsa; Maaland, Astri Fjelde; Repetto-Llamazares, Ada H.V.; Middleton, Brian; Nijland, Marcel; Visser, Lydia. (2022) Anti-CD37 radioimmunotherapy with 177Lu-NNV003 synergizes with the PARP inhibitor olaparib in treatment of non-Hodgkin's lymphoma in vitro. PLOS ONE
  Academic article
• Dahl, Mette; Husby, Simon; Eskelund, Christian W.; Besenbacher, Søren; Fjelstrup, Søren; Côme, Christophe. (2022) Correction: Expression patterns and prognostic potential of circular RNAs in mantle cell lymphoma: a study of younger patients from the MCL2 and MCL3 clinical trials (Leukemia, (2022), 36, 1, (177-188), 10.1038/s41375-021-01311-4). Leukemia
  Errata
• Riise, Jon; Meyer, Saskia; Blaas, Isaac; Chopra, Adity; Tran, Trung; Delic-Sarac, Marina. (2022) Rituximab-treated patients with lymphoma develop strong CD8 T-cell responses following COVID-19 vaccination. British Journal of Haematology
  Academic article

2021

• Lindberg, Åsa; Eskelund, Christian Winther; Albertsson-Lindblad, Alexandra; Kolstad, Arne; Laurell, Anna; Räty, Riikka. (2021) Pre-treatment health-related quality of life parameters have prognostic impact in patients >65 years with newly diagnosed mantle cell lymphoma: The Nordic Lymphoma Group MCL4 (LENA-BERIT) experience. Hematological Oncology
  Academic article
• Fowler, Nathan Hale; Dickinson, Michael; Dreyling, Martin; Martinez-Lopez, Joaquin; Kolstad, Arne; Butler, Jason. (2021) Tisagenlecleucel in adult relapsed or refractory follicular lymphoma: the phase 2 ELARA trial. Nature Medicine
  Academic article
• Lokhande, Lavanya; Kuci Emruli, Venera; Eskelund, Christian W.; Kolstad, Arne; Hutchings, Martin; Räty, Riikka. (2021) Serum proteome modulations upon treatment provides biological insight on response to treatment in relapsed mantle cell lymphoma. Cancer Reports
  Academic article
• Rodrigues, Joana M.; Nikkarinen, Anna; Hollander, Peter; Weibull, Caroline E.; Räty, Riikka; Kolstad, Arne. (2021) Infiltration of CD163-, PD-L1- and FoxP3-positive cells adversely affects outcome in patients with mantle cell lymphoma independent of established risk factors. British Journal of Haematology
  Academic article
• Ali, Muhammad; Giannakopoulou, Eirini Chrysovalantou; Li, Yingqian; Lehander, Madeleine; Virding Culleton, Stina; Yang, Weiwen. (2021) T cells targeted to TdT kill leukemic lymphoblasts while sparing normal lymphocytes. Nature Biotechnology
  Academic article
• Merrien, Magali; Wasik, Agata M.; Ljung, Elin; Morsy, Mohammad H. A.; de Matos Rodrigues, Joana; Carlsten, Mattias. (2021) Clinical and biological impact of SAMHD1 expression in mantle cell lymphoma. Virchows Archiv
  Academic article
• Blakkisrud, Johan; Løndalen, Ayca; Dahle, Jostein; Martinsen, Anne Catrine Trægde; Kolstad, Arne; Stokke, Caroline. (2021) Myelosuppression in patients treated with 177Lutetium-lilotomab satetraxetan can be predicted with absorbed dose to the red marrow as the only variable. Acta Oncologica
  Academic article
• Ask, Eivind Heggernes; Tschan-Plessl, Astrid; Gjerdingen, Thea Johanne; Hoel, Hanna Julie; Sætersmoen, Michelle Lu; Wiiger, Merete Thune. (2021) A Systemic Protein Deviation Score Linked to PD-1+ CD8+ T Cell Expansion That Predicts Overall Survival in Diffuse Large B Cell Lymphoma. Med
  Academic article
• Dahl, Mette; Husby, Simon; Eskelund, Christian W.; Besenbacher, Søren; Fjelstrup, Søren; Côme, Christophe. (2021) Expression patterns and prognostic potential of circular RNAs in mantle cell lymphoma: a study of younger patients from the MCL2 and MCL3 clinical trials. Leukemia
  Academic article

2020

• Eskelund, Christian Winther; Husby, Simon; Favero, Francesco; Klausen, Tobias Wirenfeldt; Rodriguez-Gonzalez, Francisco German; Kolstad, Arne. (2020) Clonal hematopoiesis evolves from pretreatment clones and stabilizes after end of chemotherapy in patients with MCL. Blood
  Letter to the editor
• Maaland, Astri Fjelde; Saidi, Amal; Torgue, Julien; Heyerdahl, Helen; Stallons, Tania A. Rozgaja; Kolstad, Arne. (2020) Targeted alpha therapy for chronic lymphocytic leukaemia and non-Hodgkin’s lymphoma with the anti-CD37 radioimmunoconjugate 212Pb-NNV003. PLOS ONE
  Academic article
• Lokhande, Lavanya; Emruli, Venera Kuci; Kolstad, Arne; Hutchings, Martin; Räty, Riikka; Jerkeman, Mats. (2020) Immune-related protein signature in serum stratify relapsed mantle cell lymphoma patients based on risk. BMC Cancer
  Academic article
• Eskelund, Christian Winther; Dimopoulos, Kostas; Kolstad, Arne; Glimelius, Ingrid; Räty, Riikka; Rahbek Gjerdrum, Lise Mette. (2020) Detailed Long-Term Follow-Up of Patients Who Relapsed After the Nordic Mantle Cell Lymphoma Trials: MCL2 and MCL3. HemaSphere
  Academic article
• Ferrero, Simone; Rossi, Davide; Rinaldi, Andrea; Bruscaggin, Alessio; Spina, Valeria; Eskelund, Christian W.. (2020) KMT2D mutations and TP53 disruptions are poor prognostic biomarkers in mantle cell lymphoma receiving high-dose therapy: A FIL study. Haematologica
  Academic article
• Rodrigues, Joana M.; Hassan, May; Freiburghaus, Catja; Eskelund, Christian W.; Geisler, Christian; Räty, Riikka. (2020) p53 is associated with high-risk and pinpoints TP53 missense mutations in mantle cell lymphoma. British Journal of Haematology
  Academic article
• Kolstad, Arne; Illidge, Tim; Bolstad, Nils; Spetalen, Signe; Madsbu, Ulf Erik; Stokke, Caroline. (2020) Phase 1/2a study of 177Lu-lilotomab satetraxetan in relapsed/refractory indolent non-Hodgkin lymphoma. Blood Advances
  Academic article
• Løndalen, Ayca; Blakkisrud, Johan; Rootwelt-Revheim, Mona-Elisabeth; Madsbu, Ulf Erik; Dahle, Jostein; Kolstad, Arne. (2020) FDG PET/CT parameters and correlations with tumor-absorbed doses in a phase 1 trial of 177Lu-lilotomab satetraxetan for treatment of relapsed non-Hodgkin lymphoma. European Journal of Nuclear Medicine and Molecular Imaging
  Academic article

2019

• Maaland, Astri Fjelde; Heyerdahl, Helen; O'Shea, Adam; Eiriksdóttir, Bergthora; Pascal, Veronique; Andersen, Jan Terje. (2019) Targeting B-cell malignancies with the beta-emitting anti-CD37 radioimmunoconjugate 177Lu-NNV003. European Journal of Nuclear Medicine and Molecular Imaging
  Academic article
• Köksal, Hakan; Dillard, Pierre; Josefsson, Sarah Elisabet; Maggadottir, Solrun Melkorka; Pollmann, Sylvie Mireille; Fåne, Anne. (2019) Preclinical development of CD37CAR T-cell therapy for treatment of B-cell lymphoma. Blood Advances
  Academic article
• Josefsson, Sarah Elisabet; Beiske, Klaus; Blaker, Yngvild Nuvin; Førsund, Mette S; Holte, Harald; Østenstad, Bjørn. (2019) TIGIT and PD-1 mark intratumoral T cells with reduced effector function in B-cell non-Hodgkin lymphoma. Cancer immunology research
  Academic article

2018

• Eskelund, Christian Winther; Albertsson-Lindblad, Alexandra; Kolstad, Arne; Laurell, Anna; Räty, Riikka; Pedersen, Lone Bredo. (2018) Lenalidomide plus bendamustine-rituximab does not overcome the adverse impact of TP53 mutations in mantle cell lymphoma. Haematologica
  Letter to the editor
• Jerkeman, Mats; Eskelund, Christian Winther; Hutchings, Martin; Räty, Riikka; Wader, Karin Fahl; Laurell, Anna. (2018) Ibrutinib, lenalidomide, and rituximab in relapsed or refractory mantle cell lymphoma (PHILEMON): a multicentre, open-label, single-arm, phase 2 trial. The Lancet Haematology
  Academic article
• Barzenje, Dlawer Abdulla; Kolstad, Arne; Ghanima, Waleed Khalid; Holte, Harald. (2018) Long-term outcome of patients with solitary plasmacytoma treated with radiotherapy: A population-based, single-center study with median follow-up of 13.7 years. Hematological Oncology
  Academic article
• Stokke, Caroline; Blakkisrud, Johan; Løndalen, Ayca; Dahle, Jostein; Martinsen, Anne Catrine Trægde; Holte, Harald. (2018) Pre-dosing with lilotomab prior to therapy with 177Lu-lilotomab satetraxetan significantly increases the ratio of tumor to red marrow absorbed dose in non-Hodgkin lymphoma patients. European Journal of Nuclear Medicine and Molecular Imaging
  Academic article
• Blakkisrud, Johan; Holtedahl, Jon Erik; Løndalen, Ayca; Dahle, Jostein; Bach-Gansmo, Tore; Holte, Harald. (2018) Biodistribution and dosimetry results from a phase 1 trial of therapy with the antibody-Radionuclide conjugate 177Lu-Lilotomab satetraxetan. Journal of Nuclear Medicine
  Academic article
• Holte, Harald; Beiske, Klaus; Boyle, Merrill; Trøen, Gunhild; Blaker, Yngvild Nuvin; Myklebust, June. (2018) The MCL35 gene expression proliferation assay predicts high-risk MCL patients in a Norwegian cohort of younger patients given intensive first line therapy. British Journal of Haematology
  Academic article

2017

• Myklebust, June; Brody, Joshua; Kohrt, Holbrook E.; Kolstad, Arne; Czerwinski, Debra K; Waelchli, Sebastien. (2017) Distinct patterns of B-cell receptor signaling in non-Hodgkin lymphomas identified by single-cell profiling. Blood
  Academic article
• Barzenje, Dlawer Abdulla; Holte, Harald; Fosså, Alexander; Ghanima, Waleed Khalid; Liestøl, Knut; Delabie, Jan. (2017) Long-term outcome for patients with early stage marginal zone lymphoma and mantle cell lymphoma. Leukemia and Lymphoma
  Academic article
• Blakkisrud, Johan; Løndalen, Ayca Muftuler; Dahle, Jostein; Turner, Simon R.; Holte, Harald; Kolstad, Arne. (2017) Red Marrow–Absorbed Dose for Non-Hodgkin Lymphoma Patients Treated with 177Lu-Lilotomab Satetraxetan, a Novel Anti-CD37 Antibody–Radionuclide Conjugate. Journal of Nuclear Medicine
  Academic article
• Blakkisrud, Johan; Løndalen, Ayca Muftuler; Martinsen, Anne Catrine Trægde; Dahle, Jostein; Holtedahl, Jon Erik; Bach-Gansmo, Tore. (2017) Tumor absorbed dose for non-Hodgkin’s lymphoma patients treated with the novel anti-CD37 antibody radionuclide conjugate 177Lu-lilotomab satetraxetan. Journal of Nuclear Medicine
  Academic article
• Josefsson, Sarah Elisabet Göthberg; Huse, Kanutte; Kolstad, Arne; Beiske, Klaus; Pende, Daniela; Steen, Chloe Beate. (2017) T cells expressing checkpoint receptor TIGIT are enriched in follicular lymphoma tumors and characterized by reversible suppression of T-cell receptor signaling. Clinical Cancer Research
  Academic article
• Wogsland, Cara Ellen; Greenplate, Allison Rae; Kolstad, Arne; Myklebust, June; Irish, Jonathan Michael; Huse, Kanutte. (2017) Mass cytometry of follicular lymphoma tumors reveals intrinsic heterogeneity in proteins including HLA-DR and a deficit in nonmalignant plasmablast and germinal center B-cell populations. Cytometry Part B: Clinical Cytometry
  Academic article
• Eskelund, Christian W.; Dahl, Christina; Hansen, Jakob W; Westman, Maj; Kolstad, Arne; Pedersen, Lone B.. (2017) TP53 mutations identify younger mantle cell lymphoma patients who do not benefit from intensive chemoimmunotherapy. Blood
  Academic article

2016

• Hoster, E.; Geisler, C.H.; Doorduijn, J.; Van Der Holt, Der; Walewski, J.; Bloehdorn, J.. (2016) Total body irradiation after high-dose cytarabine in mantle cell lymphoma: A comparison of Nordic MCL2, HOVON-45, and European MCL Younger trials. Leukemia
  Letter to the editor
• Albertsson-Lindblad, Alexandra; Kolstad, Arne; Laurell, Anna; Räty, Riikka; Grønbæk, Kirsten; Sundberg, Jan. (2016) Lenalidomide-bendamustine-rituximab in patients older than 65 years with untreated mantle cell lymphoma. Blood
  Academic article
• Kolstad, Arne; Pedersen, Lone Bredo; Eskelund, Christian W.; Husby, Simon; Grønbæk, Kirsten; Jerkeman, Mats. (2016) Molecular monitoring after autologous stem cell transplantation and preemptive Rituximab treatment of molecular relapse; results from the Nordic mantle cell lymphoma studies (MCL2 and MCL3) with median follow-up of 8.5 years. Biology of Blood and Marrow Transplantation
  Academic article
• Mensali, Nadia; Fan, Ying; Oei, Vincent Yi Sheng; Yang, Weiwen; Walseng, Even; Kumari, Shraddha. (2016) Targeting B-cell neoplasia with T-cell receptors recognizing a CD20-derived peptide on patient-specific HLA. Oncoimmunology
  Academic article
• Kolstad, Arne; Guren, Tormod Kyrre; Kvaløy, Stein Olav; Christoffersen, Thoralf. (2016) Monoklonale antistoffer i cancerterapi. Universitetet i Oslo
  Chapter
• Eskelund, Christian W.; Kolstad, Arne; Jerkeman, Mats; Räty, Riikka; Laurell, Anna; Eloranta, Sandra. (2016) 15-year follow-up of the Second Nordic Mantle Cell Lymphoma trial (MCL2): prolonged remissions without survival plateau. British Journal of Haematology
  Academic article
• Holm, Kristine Lillebø; Indrevær, Randi Larsen; Myklebust, June; Kolstad, Arne; Moskaug, Jan Øivind; Naderi, Elin Hallan. (2016) Myeloid cell leukaemia 1 has a vital role in retinoic acid-mediated protection of Toll-like receptor 9-stimulated B cells from spontaneous and DNA damage-induced apoptosis. Immunology
  Academic article
• Smeland, Knut Bjøro; Kiserud, Cecilie E.; Lauritzsen, Grete Fossum; Blystad, Anne Kirsti; Fagerli, Unn-Merete; Falk, Ragnhild Sørum. (2016) A national study on conditional survival, excess mortality and second cancer after high dose therapy with autologous stem cell transplantation for non-Hodgkin lymphoma. British Journal of Haematology
  Academic article

2015

• Kolstad, Arne; Olweus, Johanna. (2015) “In situ” vaccination for systemic effects in follicular lymphoma. Oncoimmunology
  Short communication
• Barzenje, Dlawer Abdulla; Småstuen, Milada C; Liestøl, Knut; Fosså, Alexander; Delabie, Jan; Kolstad, Arne. (2015) Radiotherapy compared to other strategies in the treatment of stage I/II follicular lymphoma: A study of 404 patients with a median follow-up of 15 years. PLOS ONE
  Academic article
• Blaker, Yngvild Nuvin; Brodtkorb, Marianne; Maddison, John; Hveem, Tarjei Sveinsgjerd; Nesheim, John Arne; Mohn, Hans Martin. (2015) Computerized image analysis of the Ki-67 proliferation index in mantle cell lymphoma. Histopathology
  Academic article
• Kolstad, Arne; Kumari, Shraddha; Walczak, Mateusz; Madsbu, Ulf Erik; Hagtvedt, Trond; Bogsrud, Trond. (2015) Sequential intranodal immunotherapy induces antitumor immunity and correlated regression of disseminated follicular lymphoma. Blood
  Academic article
• Blix, Egil Støre; Kildal, Anders Benjamin; Bertelsen, Eirin Listau; Waage, Anders; Myklebust, June; Kolstad, Arne. (2015) Content of endothelial progenitor cells in autologous stem cellgrafts predict survival after transplantation for multiplemyeloma. Biology of Blood and Marrow Transplantation
  Academic article
• Husby, Simon; Ralfkiær, Ulrik; Garde, Christian; Zandi, Roza; Ek, Sara; Kolstad, Arne. (2015) miR-18b overexpression identifies mantle cell lymphoma patients with poor outcome and improves the MIPI-B prognosticator. Blood
  Academic article
• Smeland, Knut Halvor Bjøro; Kiserud, Cecilie E.; Lauritzsen, Grete Fossum; Fagerli, Unn-Merete; Falk, Ragnhild Sørum; Fluge, Øystein. (2015) Conditional survival and excess mortality after high-dose therapy with autologous stem cell transplantation for adult refractory or relapsed Hodgkin lymphoma in Norway. Haematologica
  Academic article

2014

• Husøy, Magnus Andreas Rognlien; Brinch, Lorentz; Tjønnfjord, Geir Erland; Gedde-Dahl, Tobias Jr.; Heldal, Dag; Holme, Pål Andre. (2014) Allogen stamcelletransplantasjon hos voksne 1985-2012. Tidsskrift for Den norske legeforening (Tidsskriftet)
  Academic article
• Nordström, Lena; Sernbo, Sandra; Eden, Patrik; Grønbæk, Kirsten; Kolstad, Arne; Räty, Riikka. (2014) SOX11 and TP53 add prognostic information to MIPI in a homogenously treated cohort of mantle cell lymphoma - a Nordic Lymphoma Group study. British Journal of Haematology
  Academic article
• Bersvendsen, Hanne; Kolstad, Arne; Blystad, Anne Kirsti; Aurlien, Ellen; Fosså, Alexander; Kvaløy, Stein Olav. (2014) Multimodal treatment with ALL-like chemotherapy, Auto-SCT and radiotherapy for lymphoblastic lymphoma. Acta Oncologica
  Academic article
• Blaker, Yngvild Nuvin; Eide, Marianne Brodtkorb; Liestøl, Knut; Lauritzsen, Grete Fossum; Kolstad, Arne; Fosså, Alexander. (2014) High dose chemotherapy with autologous stem cell transplant for patients with transformed B-cell non-Hodgkin lymphoma in the rituximab era. Leukemia and Lymphoma
  Academic article
• Kolstad, Arne; Laurell, Anna; Jerkeman, Mats; Gronbaek, Kirsten; Elonen, Erkki; Räty, Riikka. (2014) Nordic MCL3 study: 90Y-ibritumomab-tiuxetan added to BEAM/C in non-CR patients before transplant in mantle cell lymphoma. Blood
  Academic article

2013

• Smeland, Knut Bjøro; Kiserud, Cecilie E.; Lauritzsen, Grete Fossum; Blystad, Anne Kirsti; Fagerli, Unn Merete; Fluge, Øystein. (2013) Høydosebehandling med autolog stamcellestøtte ved lymfom i Norge 1987 - 2008. Tidsskrift for Den norske legeforening (Tidsskriftet)
  Academic article
• Smeland, Knut Halvor Bjøro; Kiserud, Cecilie E.; Lauritzsen, Grete Fossum; Blystad, Anne Kirsti; Fagerli, Unn-Merete; Fluge, Øystein. (2013) High dose therapy with autologous stem cell support for lymphoma in Norway 1987-2008. Tidsskrift for Den norske legeforening (Tidsskriftet)
  Academic article
• Myklebust, June; Irish, Jonathan M.; Brody, Joshua; Czerwinski, Debra K; Houot, Roch; Kohrt, Holbrook E.. (2013) High PD-1 expression and suppressed cytokine signaling distinguish T cells infiltrating follicular lymphoma tumors from peripheral T cells. Blood
  Academic article
• Smeland, Knut Halvor Bjøro; Kiserud, Cecilie E.; Lauritzsen, Grete Fossum; Fosså, Alexander; Hammerstrøm, Jens; Fagerli, Unn-Merete. (2013) High dose therapy with autologous stem cell support for lymphoma-from experimental to standard treatment. Tidsskrift for Den norske legeforening (Tidsskriftet)
  Academic article
• Dahle, Jostein; Repetto-Llamazares, Ada H.V.; Mollatt, Camilla Sivertsen; Melhus, Katrine Brustad; Bruland, Øyvind; Kolstad, Arne. (2013) Evaluating Antigen Targeting and Anti-tumor Activity of a New Anti-CD37 Radioimmunoconjugate Against Non-Hodgkin's Lymphoma. Anticancer Research
  Academic article
• Holte, Harald; Leppä, Sirpa; Bjørkholm, Mikaela; Fluge, Øystein; Jyrkkio, S.; Delabie, Jan. (2013) Dose-densified chemoimmunotherapy followed by systemic central nervous system prophylaxis for younger high-risk diffuse large B-cell/follicular grade 3 lymphoma patients: results of a phase II Nordic Lymphoma Group study. Annals of Oncology
  Academic article

2012

• Abrahamsen, Ingerid Weum; Kjellevoll, Synneva; Greve-Isdahl, Margrethe; Mensali, Nadia; Waelchli, Sebastien; Kumari, Shraddha. (2012) T cells raised against allogeneic HLA-A2/CD20 kill primary follicular lymphoma and acute lymphoblastic leukemia cells. International Journal of Cancer
  Academic article
• Blix, Egil Støre; Irish, Jonathan M.; Husebekk, Anne; Delabie, Jan; Tierens, Anne; Myklebust, June. (2012) Altered BCR and CD40 signalling are associated with clinical outcome in small lymphocytic lymphoma/chronic lymphocytic leukaemia and marginal zone lymphoma patients. British Journal of Haematology
  Reader opinion piece
• Fosså, Alexander; Fiskvik, Idun Hege; Kolstad, Arne; Lauritzsen, Grete Fossum; Aurlien, Ellen; Blystad, Anne Kirsti. (2012) Two escalated followed by six standard BEACOPP in advanced-stage high-risk classical Hodgkin lymphoma: high cure rates but increased risk of aseptic osteonecrosis. Annals of Oncology
  Academic article
• Fløisand, Yngvar; Brinch, Lorentz; Gedde-Dahl, Thobias; Tjønnfjord, Geir Erland; Dybedal, Ingunn; Holte, Harald. (2012) Ultra-short course sirolimus contributes to effective GVHD prophylaxis after reduced-intensity allogeneic hematopoietic cell transplantation. Bone Marrow Transplantation
  Academic article
• Geisler, Christian H.; Kolstad, Arne; Laurell, Anna; Jerkeman, Mats; Räty, Riikka; Andersen, Niels S. (2012) Nordic MCL2 trial update: six-year follow-up after intensive immunochemotherapy for untreated mantle cell lymphoma followed by BEAM or BEAC plus autologous stem-cell support: still very long survival but late relapses do occur. British Journal of Haematology
  Academic article
• Blix, Egil Støre; Irish, Jonathan M.; Husebekk, Anne; Delabie, Jan; Forfang, Lise; Tierens, Anne. (2012) Phospho-spesific flow cytometry identifies aberrant signaling in indolent B-cell lymphoma. BMC Cancer
  Academic article

2011

• Eide, Marianne Brodtkorb; Lauritzsen, Grete Fossum; Kvalheim, Gunnar; Kolstad, Arne; Fagerli, Unn-Merete; Maisenhölder, Martin. (2011) High dose chemotherapy with autologous stem cell support for patients with histologically transformed B-cell non-Hodgkin lymphomas. A Norwegian multi centre phase II study. British Journal of Haematology
  Academic article
• Yri, Olav Erich; Torfoss, Dag; Hungnes, Olav; Østenstad, Bjørn; Ekanger, Roald; Wader, Karin Fahl. (2011) LYMPHOMA PATIENTS TREATED WITH RITUXIMAB-CONTAINING REGIMENS DO NOT ACHIEVE PROTECTIVE SEROLOGICAL RESPONSES TO H1N1 INFLUENZA VIRUS AFTER VACCINATION. Annals of Oncology
  Abstract
• Hadzidimitriou, Anastasia; Agathangelidis, Andreas; Darzentas, Nikos; Murray, Fiona; Delfau-Larue, Marie-Helene; Pedersen, Lone Bredo. (2011) Is there a role for antigen selection in mantle cell lymphoma? Immunogenetic support from a series of 807 cases. Blood
  Academic article
• Yri, Olav Erich; Torfoss, Dag; Hungnes, Olav; Tierens, Anne; Waalen, Kristian; Nordøy, Tone. (2011) Rituximab blocks protective serologic response to influenza A (H1N1) 2009 vaccination in lymphoma patients during or within 6 months after treatment. Blood
  Academic article

2010

• Geisler, Christian H.; Kolstad, Arne; Laurell, Anna; Räty, Riikka; Jerkeman, Mats; Eriksson, Mikael. (2010) The Mantle Cell Lymphoma International Prognostic Index (MIPI) is superior to the International Prognostic Index (IPI) in predicting survival following intensive first-line immunochemotherapy and autologous stem cell transplantation (ASCT). Blood
  Academic article
• Myklebust, June; Irish, Jonathan Michael; Brody, Joshua; Alizadeh, Ash A.; Czerwinski, Debra; Houot, Roch. (2010) NF-kappa B Signaling In Response to CpG Stratifies Mantle Cell Lymphoma Patient Outcome. Blood
  Abstract
• Holte, Harald; Leppä, Sirpa; Björkholm, Magnus; Fluge, Øystein; Jyrkkio, Sirkku; Delabie, Jan. (2010) R-CHOEP-14 x 6 Followed by Systemic CNS Prophylaxis for Diffuse Large B-Cell Lymphoma/Follicular Lymphoma Grade 3 with Age Adjusted IPI Score 2-3: Final Results of a Nordic Lymphoma Group Phase 2 Study Including 156 Patients Aged 18-65 Years. Blood
  Abstract
• Kolstad, Arne; Kumari, Shraddha; Kvalheim, Gunnar; Bogsrud, Trond; Madsbu, Ulf Erik; Hagtvedt, Trond. (2010) A Novel Cancer Vaccine Strategy In Previously Untreated Patients with Stage III/IV Follicular Lymphoma Generates Tumor-Reactive T Cells and Clinical Response. Blood
  Abstract

2009

• Myklebust, June; Irish, J.M.; Houot, Roch; Brody, Joshua; Czerwinski, Debra K; Alizadeh, Ash A.. (2009) A Subpopulation of Follicular Lymphoma Tumor Infiltrating T Cells Shows Suppressed Common Gamma Chain Cytokine Signaling. Blood
  Abstract
• Geisler, Christian H.; Kolstad, Arne; Laurell, Anna; Räty, Riikka. (2009) Mantle cell lymphoma - does primary intensive immunochemotherapy improve overall survival for younger patients?. Leukemia and Lymphoma
  Academic literature review
• Andersen, NS; Pedersen, LB; Laurell, A; Elonen, E; Kolstad, Arne; Boesen, AM. (2009) Pre-Emptive Treatment With Rituximab of Molecular Relapse After Autologous Stem Cell Transplantation in Mantle Cell Lymphoma. Journal of Clinical Oncology
  Academic article
• Kolstad, Arne; Guren, Tormod K.; Kvaløy, Stein Olav; Christoffersen, Thoralf. (2009) Monoklonale antistoffer i cancerterapi. Universitetet i Oslo
  Academic chapter/article/Conference paper
• Kolstad, Arne; Laurell, Anna; Andersen, Niels S.; Elonen, Erkki; Räty, Riikka; Pedersen, Lone Bredo. (2009) (90)y-Ibritumumab Tiuxetan (Zevalin (R))-BEAM/C with Autologous Stem Cell Support as Frontline Therapy for Advanced Mantle Cell Lymphoma.- Preliminary Results From the Third Nordic MCL Phase II Study (MCL3). Blood
  Abstract
• Houot, Roch; Goldstein, Matthew J.; Kohrt, Holbrook E.; Myklebust, June; Alizadeh, Ash A.; Lin, Jack T.. (2009) Therapeutic effect of CD137 immunomodulation in lymphoma and its enhancement by T-reg depletion. Blood
  Academic article

2005

• Kaminski, MS; Tuck, M; Estes, J; Kolstad, Arne; Ross, CW; Zasadny, K. (2005) Tositumomab and lodine 131 Tositumomab (Bexxar therapeutic regimen) as initial therapy for follicular B-cell lymphoma. New England Journal of Medicine
  Academic article

2004

• Risberg, Terje; Bremnes, Yngve; Kolstad, Arne; Holte, Harald; Wist, Erik; Mella, Olav. (2004) Tilbud om komplementærbehandling i sykehus. Tidsskrift for Den norske legeforening (Tidsskriftet)
  Academic article

1999

• Kolstad, Arne. (1999) Effects of Changing Government Policies on Sickness Absence Behaviour. NOVA Rapport (14)
  Report